Former Nordion CEO Steve West has been appointed to the board of directors of TSO3, the Quebec City-based company announced Tuesday.
TSO3 (TSE: TOS) makes low-temperature sterilization technology for medical devices. Its president and CEO, Ric Rumble, said Mr. West’s more than 30 years in the health and life sciences sector will be valuable as the firm evaluates its U.S. listing options.
“He also has gained extensive global expertise from his tenure at Nordion, MDS and Unilever Canada, which we expect to help guide our fast-growing global business,” Mr. Rumble said in a statement.
OBJ360 (Sponsored)
How to mitigate AI legal risks by asking the right questions
Does AI hallucinate? According to local employment law expert Zoriana Priadka of Emond Harnden, it does. Find out how to mitigate your risk as an employer.
Be a part of OBJ’s City Building 2024
Ottawa is undergoing a building boom that, as we speak, is shaping the future of the city. The cranes dotting Ottawa’s skyline are saluting the city’s transformation, with several megaprojects
Mr. West, who also chairs the board of the Innovation Centre at Bayview Yards, said TSO3’s new sterilization product addresses an “unmet need” in hospitals and he looks forward to working with the firm to assist in the rollout of the product.
“TSO3 has clearly entered the commercialization stage of its development with the significant ramp in sales during the third quarter and completion of its new U.S. distribution and customer support facility,” he said in a statement.
In midday trading on the Toronto Stock Exchange, TSO3’s stock jumped six cents to $1.76. ’
